首页> 美国卫生研究院文献>World Journal of Orthopedics >Teriparatide anabolic therapy as potential treatment of type II dens non-union fractures
【2h】

Teriparatide anabolic therapy as potential treatment of type II dens non-union fractures

机译:Teriparatide合成代谢疗法可治疗II型Dens骨不连骨折

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Odontoid fractures account for 5% to 15% of all cervical spine injuries and 1% to 2% of all spine fractures. Type II fractures are the most common fracture pattern in elderly patients. Treatment (rigid and non-rigid immobilization, anterior screw fixation of the odontoid and posterior C1-C2 fusion) remains controversial and represents a unique challenge for the treating surgeon. The aims of treatment in the elderly is to quickly restore pre-injury function while decreasing morbidity and mortality associated with inactivity, immobilization with rigid collar and prolonged hospitalization. Conservative treatment of type II odontoid fractures is associated with relatively high rates of non-union and in a few cases delayed instability. Options for treatment of symptomatic non-unions include surgical fixation or prolonged rigid immobilization. In this report we present the case of a 73-year-old woman with post-traumatic odontoid non-union successfully treated with Teriparatide systemic anabolic therapy. Complete fusion and resolution of the symptoms was achieved 12 wk after the onset of the treatment. Several animal and clinical studies have confirmed the potential role of Teriparatide in enhancing fracture healing. Our case suggests that Teriparatide may have a role in improving fusion rates of C2 fractures in elderly patients.
机译:齿状突骨折占所有颈椎损伤的5%至15%,占所有脊柱骨折的1%至2%。 II型骨折是老年患者中最常见的骨折类型。治疗(刚性和非刚性固定,齿状突的前螺钉固定和后C1-C2融合)仍存在争议,对治疗外科医生而言是一个独特的挑战。老年人的治疗目标是快速恢复损伤前的功能,同时降低与不活动,僵硬的固定和长期住院相关的发病率和死亡率。 Ⅱ型齿状突骨折的保守治疗与较高的骨不连率有关,在某些情况下还延迟了不稳定性。有症状的不愈合的治疗选择包括外科手术固定或长时间的僵化固定。在本报告中,我们介绍了一名73岁的外伤性齿状突不愈合联合疗法成功通过特立帕肽系统性合成代谢疗法治疗的妇女的病例。治疗开始后12周,症状完全融合并缓解。多项动物和临床研究已经证实了特立帕肽在增强骨折愈合中的潜在作用。我们的案例表明,特立帕肽可能在改善老年患者C2骨折的融合率中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号